Inflammation Related to Muted Pleasure Feelings in Depression
the Psychiatry Advisor take:
People that have high levels of inflammation in their brain may also have more stubborn symptoms of depression.
Jennifer Felger, PhD, of Emory University School of Medicine, Atlanta, and colleagues examined 48 patients with depression. Those with high levels of high levels of the inflammatory marker CRP (C-reactive protein) were linked with a “communication failure,” as seen through brain scans, between regions of the brain important for motivation and reward.
The findings, according to Felger, reinforce the idea that high-inflammation depression is a distinct form of the mood disorder, and should have treatments developed specifically for it, she wrote in the journal Molecular Psychiatry.
In particular, many people with depression, despite taking antidepressants, still suffer from anhedonia, or the inability to feel pleasure. And in particular, those with high CRPs levels were particular susceptible to it.
“Our data suggest that by blocking inflammation or its effects on the brain, we may be able to reverse anhedonia and help depressed individuals who fail to respond to antidepressants,” Felger said in a statement.
The researchers are next planning to test whether L-DOPA, a drug that targets the brain chemical dopamine, can increase connectivity in reward-related brain regions in patients with high-inflammation depression.
Depressed patients with high levels of an inflammatory marker in their blood were particularly susceptible to anhedonia.
About one third of people with depression have high levels of inflammation markers in their blood. New research indicates that persistent inflammation affects the brain in ways that are connected with stubborn symptoms of depression, such as anhedonia, the inability to experience pleasure.
The results were published online in Molecular Psychiatry.
The findings bolster the case that the high-inflammation form of depression is distinct, and are guiding researchers' plans to test treatments tailored for it.
Anhedonia is a core symptom of depression that is particularly difficult to treat, says lead author Jennifer Felger, PhD, assistant professor of psychiatry and behavioral sciences at Emory University School of Medicine and Winship Cancer Institute.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders